MustGrow Posts Positive Field Trials Results – The Daily Dive

To start off this week’s Daily Dive, we see the return of Colin Bletsky, COO and Director of MustGrow Biologics Corp (CSE: MGRO). Colin joins us to share his company’s recent field trial results surrounding the banana Panama Disease, the expected next developments, and their recent private placement. He also dives deep in discussing the challenges that the agricultural system faces in the current environment.

MustGrow Biologics Corp. is an agriculture biotech company focused on providing natural, science-based biological solutions to replace synthetic chemicals used in high-value crops such as fruit & vegetables. The company uses mustard plant components to deliver high-quality disease, insect pest, and weed control, as well as to apply their technology in the most natural and sustainable way possible to growers, the environment, and customers throughout the world.

FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.